MENEGATTI, MARZIA
 Distribuzione geografica
Continente #
EU - Europa 5.609
NA - Nord America 5.153
AS - Asia 4.276
Continente sconosciuto - Info sul continente non disponibili 824
SA - Sud America 433
AF - Africa 126
OC - Oceania 37
Totale 16.458
Nazione #
US - Stati Uniti d'America 4.890
GB - Regno Unito 1.824
SG - Singapore 1.284
CN - Cina 1.241
IT - Italia 927
DE - Germania 709
SE - Svezia 521
RU - Federazione Russa 452
BD - Bangladesh 381
HK - Hong Kong 335
BR - Brasile 279
FR - Francia 242
VN - Vietnam 229
IN - India 222
NL - Olanda 219
CA - Canada 171
TR - Turchia 169
UA - Ucraina 158
IE - Irlanda 147
FI - Finlandia 121
KR - Corea 113
EU - Europa 82
ID - Indonesia 66
ES - Italia 51
CO - Colombia 50
JP - Giappone 48
IR - Iran 46
DK - Danimarca 45
AR - Argentina 43
MX - Messico 43
AU - Australia 30
BE - Belgio 30
TN - Tunisia 24
PL - Polonia 23
GR - Grecia 20
IQ - Iraq 20
CI - Costa d'Avorio 19
EG - Egitto 18
CH - Svizzera 17
PK - Pakistan 16
VE - Venezuela 16
SA - Arabia Saudita 15
AT - Austria 14
TH - Thailandia 14
CL - Cile 13
PT - Portogallo 13
ZA - Sudafrica 13
BG - Bulgaria 12
UZ - Uzbekistan 12
PE - Perù 11
DZ - Algeria 10
EC - Ecuador 10
CR - Costa Rica 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
HU - Ungheria 8
KE - Kenya 8
MA - Marocco 8
JO - Giordania 7
SK - Slovacchia (Repubblica Slovacca) 7
NZ - Nuova Zelanda 6
PA - Panama 6
PH - Filippine 6
ET - Etiopia 5
JM - Giamaica 5
LT - Lituania 5
MY - Malesia 5
NO - Norvegia 5
TW - Taiwan 5
AL - Albania 4
CZ - Repubblica Ceca 4
GT - Guatemala 4
HR - Croazia 4
IL - Israele 4
NI - Nicaragua 4
NP - Nepal 4
PY - Paraguay 4
UY - Uruguay 4
AZ - Azerbaigian 3
BZ - Belize 3
DO - Repubblica Dominicana 3
HN - Honduras 3
LU - Lussemburgo 3
MD - Moldavia 3
NG - Nigeria 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SN - Senegal 3
AF - Afghanistan, Repubblica islamica di 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
GA - Gabon 2
KW - Kuwait 2
KZ - Kazakistan 2
LV - Lettonia 2
ML - Mali 2
MU - Mauritius 2
Totale 15.681
Città #
Southend 1.641
Singapore 760
Ashburn 506
Chandler 339
Hong Kong 311
San Jose 301
Milan 280
Seattle 279
Beijing 246
Hanover 242
Council Bluffs 241
Dallas 202
Princeton 183
Santa Clara 165
Wilmington 155
Dublin 147
Jacksonville 139
Fairfield 128
Los Angeles 123
Frankfurt am Main 113
Ann Arbor 101
New York 94
Bengaluru 90
Shanghai 90
Woodbridge 86
Mountain View 85
Lauterbourg 84
Nanjing 79
Redmond 72
Des Moines 69
Moscow 67
Ottawa 66
Buffalo 65
Boardman 64
Houston 62
Rome 60
Dearborn 58
Hanoi 57
Ho Chi Minh City 55
Guangzhou 54
Cambridge 47
Phoenix 44
Cangzhou 43
Sakarya 43
Serra 43
Somerville 42
Bogotá 41
São Paulo 40
Centro 38
Jakarta 37
Jinan 36
Andover 34
Hefei 34
Pisa 34
Helsinki 32
Redwood City 32
Tokyo 32
Columbus 31
Shenyang 30
Turin 28
Roxbury 27
San Diego 26
The Dalles 26
Tianjin 25
Seoul 24
Hangzhou 23
Berlin 21
Toronto 21
Istanbul 19
Nanchang 19
Paris 19
Abidjan 18
Bologna 18
Saint Petersburg 18
Shenzhen 18
Bitonto 17
Brussels 17
Medford 17
Warsaw 17
Athens 16
Changsha 16
Eitensheim 16
Hebei 16
Jiaxing 16
Kunming 16
Zhengzhou 16
Ankara 15
Chicago 15
Da Nang 15
London 15
Montreal 15
Naples 15
Orem 15
Bristol 14
Chennai 14
Buenos Aires 13
Mumbai 13
Munich 13
Düsseldorf 12
Dong Ket 11
Totale 9.397
Nome #
Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders 531
No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age 406
European Network of Rare Bleeding Disorders (EN-RBD) 394
Treatment of rare factor deficiencies other than hemophilia 390
Molecular characterization of an Italian patient with plasminogen deficiency and ligneous conjunctivitis 378
Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency 366
Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes 333
Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis 292
Genetic diagnosis of haemophilia and other inherited bleeding disorders 285
International Rare Bleeding Disorders Database 274
Genetics of rare bleeding disorders 251
An international registry of patients with plasminogen deficiency (HISTORY) 249
Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis 248
Database on rare bleeding disorder (RBDS) : phenotype and genotype analysis on 400 affected patients 243
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 242
Understanding the Impact of Aberrant Splicing in Coagulation Factor V Deficiency. 229
Exploring the global landscape of genetic variation in coagulation factor XI deficiency 228
Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency 221
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database 219
Identification of four novel polymorphisms in the Aα and γ fibrinogen genes and analysis of association with plasma levels of the protein 218
A rare inherited coagulation disorder : combined homozygous factor VII and factor X deficiency 217
Dalla diagnosi di portatrice di emofilia alla diagnosi prenatale 211
Rare bleeding disorders 209
State of the art of rare bleeding disorders database (RBDD) 208
Effect of adenosine derivatives on in vitro thrombus formation induced by shear stress 207
Future perspective of international registry on rare inherited bleeding disorder 200
Establishment of a European network of Rare Bleeding Disorders (RBDs) 197
International Registry of rare bleeding disorders (RBD) 192
Introduction. Rare bleeding disorders : general aspects of clinical features, diagnosis, and management 190
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes 188
Molecular characterization in an Italian patient with plasminogen deficiency and ligneous conjunctivitis 186
Factor X deficiency 183
Kinetics studies of a naturally occurring mutation on Factor X (FX) gene (G222D) 178
Performance of clinical laboratories for DNA analyses to detect thrombophilia mutations 176
Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency 176
Relatively poor performance of clinical laboratories for DNA analyses in the detection of two thrombophilic mutations : a cause for concern 171
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders : results from the European Network of Rare Bleeding Disorders 171
Molecular characterization in an Italian patient with plasminogen deficiency and ligneous conjunctivitis 166
Post-partum haemorrhage in women with rare bleeding disorders 165
Italian experience in the assessment of performance of clinical laboratories for DNA analyses to detect three thrombophilic mutations 164
Association between thrombin generation and bleeding severity in 41 patients with coagulation factor VII deficiency 164
Two adjacent homozygous mutations on EGF2 domain of factor X (FX) gene lead to severe FX deficiency 160
European registry of rare bleeding disorders 160
Diagnosis of FXIII deficiency: data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories 160
Establishment of a European network of rare bleeding disorders 159
Factor XIII deficiency : preliminary results of the PRO-RBDD project 158
A very rare simultaneous presence of a ring chromosome 13 and a splicing site mutation on Factor X gene 158
Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies 155
Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management 155
Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran 154
A very rare simultaneous presence of a ring chromosome 13 and a splicing site mutation on Factor X gene 154
Genotype analysis of rare coagulation factor deficiency cases from India 152
Thrombin Generation in Patients with Idiopathic Sudden Sensorineural Hearing Loss 150
The role of factor X in blood coagulation : clinical, phenotypic and molecular analysis of a severe rare bleeding disorder 149
Effect of prothrombin 19911 A>G polymorphism on the risk of cerebral sinus-venous thrombosis 147
Gynecological and obstetrical manifestations of inherited bleeding disorders in women 145
In vitro expression studies and immunofluorescence microscopy analysis of two naturally occuring mutations on Factor X (FX) gene (G94R and D95E) 142
Molecular evaluation of a naturally occuring mutation on Factor X gene (Gly222Asp) causing severe FX deficiency 141
A recurrent Gly43Asp substitution of coagulation Factor X rigidifies its catalytic pocket and impairs catalytic activity and intracellular trafficking 138
Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency 138
Rare inherited coagulation disorders: no longer orphan and neglected 137
Detection of Factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories 136
Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories 134
Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran 130
Reduced fibrinolytic resistance in patients with factor XI deficiency : Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway 130
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes 127
In Vitro Expression Studies And Immunofluorescence Microscopy Analysis Of Two Naturally Occurring Mutations On Factor X (FX) Gene (G94R And D95E) 126
Prevalence of gain-of-function factor V Leiden and prothrombin G20210A in a large cohort of patients with rare bleeding disorders 124
Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss 123
Inherited bleeding disorders in pregnancy : rare coagulation factor defects 122
Registri nazionali ed internazionali sulle malattie rare della coagulazione 119
Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders 119
Disseminated intravascular coagulation with positive D-dimer : a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran 119
Molecular investigation of 41 patients affected by coagulation factor XI deficiency 118
Patients Informative Booklet on the Establishment of a European Network of Rare Bleeding Disorders (EN-RBD) project funded by EC (downloadable at www.rbdd.eu) 114
Combined Factor V and Factor VIII Deficiency in Rare Coagulation Disorders 114
Rare bleeding disorders 113
Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway 113
Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database 110
Frequency of the p.Gly262Asp mutation in congenital Factor X deficiency 105
A recurrent Gly43Asp substitution in coagulation Factor X rigidifies its catalytic pocket and impairs catalytic activity and intracellular trafficking 105
A homozygous duplication of the FGG exon 8-intron 8 junction causes congenital afibrinogenemia. Lessons learned from the study of a large consanguineous Turkish family 101
Report on ten new patients with congenital Factor X deficiency and the associated mutations 97
Minimal residual FXIII coagulant activity to prevent spontaneous major bleeding, on behalf of the PRO-RBDD group 94
The genetic spectrum of rare bleeding disorders 93
Genotype and phenotype report on patients with combined deficiency of factor V and factor VIII in Iran 93
Minimal factor XIII activity level to prevent major spontaneous bleeds : reply 92
Inherited bleeding disorders in pregnancy: rare coagulation factor defects 91
Clinical, Laboratory Aspects and Management of Factor X Deficiency 87
Rare bleeding disorders 84
Neonatal onset of congenital factor X deficiency : a description of two novel mutations with 6-year follow-up 82
Treatment of rare factor deficiencies in 2016 82
Management of rare acquired bleeding disorders 41
Rare coagulation defects 29
Plasminogen activation and plasmin activity are not necessary to prevent venous thrombosis/thromboembolism 17
Minimal factor XIII activity level to prevent major spontaneous bleeds 13
Rare Inherited Coagulation Disorders 10
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes 6
Two adjacent homozygous mutations on EGF2 domain of factor X (FX) gene lead to severe FX deficiency 6
null 3
Totale 16.450
Categoria #
all - tutte 42.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.115 0 60 37 76 88 73 111 75 106 141 94 254
2022/20231.388 173 133 118 137 155 267 37 136 139 23 59 11
2023/2024807 30 78 34 32 175 95 42 68 22 41 75 115
2024/20252.107 102 208 59 171 159 80 78 234 131 233 180 472
2025/20264.515 452 214 421 412 493 305 416 186 435 354 475 352
2026/2027588 284 304 0 0 0 0 0 0 0 0 0 0
Totale 16.458